Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmalogic ApS
APS
Active
Advertising protection
CVR 42323519
Brunemarksvej 17, 3480
Fredensborg
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2021 · 5 years old
23 employees
www.pharmalogic.dk
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
Pharmalogic ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
6M
12M
18M
24M
3M
2021
7M
2022
15M
2023
21M
2024
EBITDA
DKK millions
3M
2M
1M
1M
0M
1M
2021
1M
0%
2022
2M
+100%
2023
0M
-100%
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Gross profit
3.241
7.396
14.961
21.156
Staff expenses
-2.562
-6.573
-13.140
-21.157
EBITDA
678
823
1.821
-1
Depreciation & amort.
-0
-80
-91
-65
EBIT
678
743
1.730
-67
Net financials
-1
-38
-34
-123
Profit before tax
677
705
1.696
-190
Tax
154
127
402
-0
Net profit
524
578
1.294
-190
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
1.348
3.629
4.715
6.581
Equity
564
1.142
1.936
261
Long-term debt
0
0
0
0
Short-term debt
784
2.487
2.779
6.320
Total debt
784
2.487
2.779
6.320
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-0.0%
This company
2021
2024
Equity ratio
4.0%
This company
38.2%
Market median
-90% vs market
2021
2024
Return on equity
-72.7%
This company
18.4%
Market median
-495% vs market
2021
2024
Net profit margin (of gross profit)
-0.9%
This company
2021
2024
Asset turnover (of gross profit)
3.21×
This company
2021
2024
Debt / equity
24.21×
This company
0.62×
Market median
-3805% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-04-14 – 2021-12-31
View
PDF
More on Pharmalogic ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network